Impact of Therapy Optimization on the Level of Biomarkers in Patients With Decompensated Heart Failure
Impact of Therapy Optimization on the Level of Biomarkers in Patients With Acute Decompensated and Decompensated Chronic Heart Failure
Sponsor: Brahms AG
A observational or N/A phase clinical study on Decompensated Heart Failure, this trial is completed. The trial is conducted by Brahms AG and has accumulated 7 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Sep 2017 [monthly]
Unknown Status NA
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brahms AG
- Charite University, Berlin, Germany
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Berlin, Germany